| http://www.w3.org/ns/prov#value | - Last year, Dennis O???Kane, PhD, of Mayo Clinic, one of the beta-testing sites for the product, reported that he and colleagues had successfully used a customized Nanogen chip for a pharmacogenomic application, looking at SNPs in the gene for thiopurine methyl transferase (TPMT), which metabolizes immunosuppressant thiopurine drugs used to treat leukemia, Crohn???s disease, and other conditions.
|
